DNA Methylation Changes in Ovarian Tumors
Author Information
Author(s): P Chengl, C Schmutte, KF Cofer, JC Felix, MC Yu, L Dubeau
Primary Institution: USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine
Hypothesis
Are alterations in DNA methylation early events in ovarian tumorigenesis?
Conclusion
Alterations in DNA methylation are present in low malignant potential tumors and carcinomas, but not in cystadenomas.
Supporting Evidence
- Global methylation levels in LMP tumors and carcinomas were 21% and 25% lower than in cystadenomas.
- Changes in the methylation status of the MyoD1 locus were present in five of ten LMP tumors and in five of ten carcinomas.
- None of the ten cystadenomas examined showed methylation changes.
Takeaway
This study found that changes in DNA methylation happen early in the development of some ovarian tumors, but not in benign cystadenomas.
Methodology
The study compared global levels of DNA methylation and specific locus methylation in ovarian cystadenomas, LMP tumors, and carcinomas using high-pressure liquid chromatography.
Limitations
The study's sample size was relatively small, which may limit the generalizability of the findings.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website